Nifedipine Tablet, Extended Release
Product Images NDC 50742-621

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Nifedipine (NDC 50742-621). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ingenus Pharmaceuticals, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image1 (Image 01)

FDA Label Image

Image2 (Image 02)

MEAN REDUCTIONS IN TROUGH SUPINE BLOOD PRESSURE (mmHg) for Nifedipine extended-release tablets for three different doses in two studies are shown. Study 1 and 2 both evaluated 30 mg, 60 mg, and 90 mg doses. In study 1, the reductions in trough supine blood pressure ranged from 53/2.9 to 12.5/8.1, while in study 2, the reductions ranged from 76/3.8 to 10.2/5.8. The placebo response was subtracted from the results.*

FDA Label Image

Image3 (Image 03)

This is a table showing the incidence of adverse effects in patients taking Nifedipine extended-release tablets versus a placebo. The adverse effects listed include headache, flushing/heat sensation, dizziness, fatigue/asthenia, nausea, and constipation. The data is presented as percentages and based on a sample size of 370 for those taking Nifedipine and 126 for those taking the placebo.*

FDA Label Image

Image4 (Image 04)

This is a description of three different strengths of medication produced by Novast. The 30mg tablets are yellow in color and have "Novast" on one side and "33" on the other side. The 60mg tablets are pink in color and have "Novast" on one side and "36" on the other side. The 90mg tablets are brown in color and have "Novast" on one side and "39" on the other side.*

FDA Label Image

Image5 (Image 05)

FDA Label Image

Image6 (Image 06)

FDA Label Image

Image7 (Image 07)

This is a prescription drug label for a medication called NIFEdipine. It is an extended-release tablet used to treat high blood pressure. The label includes the drug's name, dosage, and safety information.*

FDA Label Image

Image8 (Image 08)

This is a description for a bottle of NIFEdipine Extended-Release Tablets, USP containing 100 tablets. The lot number is 00000000 with an expiry date of 07/00. The NIFEdipine extended-release tablets are used to treat high blood pressure and angina (chest pain), and it is normally prescribed by a physician.*

FDA Label Image

Image9 (Image 09)

This is a description of medication. The medication is NIFEdipine, in the form of extended-release tablets. The package contains 100 tablets. The rest of the text is not relevant or readable.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.